Kelonia

Developer of medicines to treat autoimmune and inflammatory conditions

placeBoston, Massachusetts, United States calendar_todayFounded 2021 groups45 employees language keloniatx.com

Registered entities

Social engagement

Social engagement: 9.7K social following, 10 posts in the last 12 months — below the industry typical range.

Investor mix

3 investors on record; lead investors include Alta Partners, Horizons Ventures, Venrock.

Investor typeCountShare
Venture capital3100%

Recent activity

21 May 2026
Milestone
regulatory
7 Jan 2026
Milestone
regulatory
6 Jan 2026
Leadership hire
Chief Development Officer
Coming soon